拜耳

Bayer shares fall 10% after Roundup cancer ruling
孟山都被罚致拜耳股价大幅下挫


美国一法院裁定孟山都的除草剂致一名场地管理员患癌,要求孟山都向后者作出巨额赔偿。孟山都的新东家拜耳的股价大幅下挫。

Shares in German pharmaceuticals and chemicals group Bayer fell almost 10 per cent in early trade on Monday, after a US court ruled that weedkiller Roundup had caused cancer in a groundskeeper and awarded him $298m in damages.

德国制药和化工集团拜耳(Bayer)的股价在周一早盘下跌近10%。此前,美国一家法院裁定除草剂农达(Roundup)致使一名场地管理员患癌,他被判获得2.98亿美元赔偿金。

The US court ruled on Friday that the maker of Roundup, US seed and chemicals group Monsanto, had failed to warn groundskeeper Dewayne Johnson as well as other consumers of the cancer risks posed by its weed killers. It awarded him $39m in compensation and $250m in punitive damages.

该法院上周五裁定,农达的制造商、美国种子和化工集团孟山都(Monsanto)未能警告场地管理员德韦恩•约翰逊(Dewayne Johnson)及其他消费者该除草剂可能致癌。该法院判处孟山都向约翰逊支付3900万美元赔偿金和2.5亿美元惩罚性赔偿。

您已阅读43%(718字),剩余57%(955字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×